ClinicalTrials.gg
RecruitingNCT07721792IM ABLE 2Updated Jul 23, 2026

IM ABLE 2: Injuries Managed With Advanced Bracing for Lower Extremities

An interventional study of Advanced Ankle Foot Orthosis (AFO) and Conventional Ankle Foot Orthosis (AFO) in Lower Limb Injury, Ankle Foot Orthosis (AFO) and Lower Limb Trauma, sponsored by University of South Florida. Recruiting at 3 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by University of South Florida · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of the study is to test different categories of ankle foot orthoses (AFOs) with patients who have had lower limb salvage, reconstruction or other problems impacting limb function.

Read the detailed description

The purpose of the study is to test different categories of ankle foot orthoses (AFOs) with patients who have had lower limb salvage, reconstruction or other problems impacting limb function. Some lower limb AFO users will decide later to amputate the affected limb to escape pain and repeated surgery requiring them to use a prosthesis instead. Benefits may include reduced pain and more function from a prosthesis.

This research will allow physicians, physical therapists, orthotists, and researchers to determine what modifications can be made to AFOs to make them more comfortable and usable. Over the course of a year, subjects will test both AFO types; a conventional (standard) AFO and an advanced (energy storing and return) AFO, in a battery of physical tests, community use, and surveys to gain a better understanding of the pros and cons of each.

Subjects will be recruited to participate in research for approximately 18 months. During the first six weeks (up to three weeks on each type of AFO), subjects will be provided with an AFO and given training on how to correctly use and maintain it, to ensure optimal use. Over the following 12 months, there will be monthly assessments including questionnaires, activity monitor uploads, device failures, and interviews to gather information on the subject's experience with AFO use.

02

Conditions studied

  • Lower Limb Injury
  • Ankle Foot Orthosis (AFO)
  • Lower Limb Trauma

Browse trials for

Keywords

  • Ankle foot orthosis (AFO)
  • activity monitor
  • lower limb injury
  • gait
  • activities of daily living
  • lower extremity trauma
03

In context

Leg Injuries

65 studies on the registry are indexed under Leg Injuries; 12 are open to participants now.

This study's planned enrollment of 75 is above the median of 58 across 48 interventional studies indexed under Leg Injuries.

Browse Leg Injuries studies →

Lead sponsor

University of South Florida is the lead sponsor of 340 studies on the registry; 65 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Lower extremity injury of any etiology requiring current use of an AFO
  • Age 18-80 years
  • 100-275 lbs
  • Greater than 1 month of AFO experience
  • Use of an AFO for activities of daily living
  • English or Spanish speaking
  • Able to comply with study procedures

Exclusion criteria

Exclusion Criteria:

  • Body mass less than 100 or greater than 275 lbs.
  • Over 80 years of age
  • Known cognitive impairment (e.g. diagnoses such as moderate/severe traumatic brain injury, dementia)
  • Inability to comply with instructions.
  • Pregnancy
  • Medical conditions that would preclude safe involvement
  • Unable to provide written .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
75 participants (estimated)

Study arms

  • Active comparator
    Conventional Ankle Foot Orthosis (AFO)

    Limited function; thermoplastic or thermoset material

    Device: Conventional Ankle Foot Orthosis (AFO)

  • Active comparator
    Advanced Ankle Foot Orthosis (AFO)

    Return stored energy; laminated; may include posterior struts; higher activity

    Device: Advanced Ankle Foot Orthosis (AFO)

Interventions

  • DeviceAdvanced Ankle Foot Orthosis (AFO)

    Subjects will be initially fit with the AFO category they do not use on a daily basis to ensure they have both AFO categories for the study. These "advanced" AFOs have been developed to offer energy-storing-and-returning (ESR) properties to the user. Advanced Ankle Foot Orthoses include designs that are widely believed to return stored energy in late stance. These designs are laminated and may include posterior struts.

    Also known as: Advanced AFO

  • DeviceConventional Ankle Foot Orthosis (AFO)

    Subjects will be initially fit with the AFO category they do not use on a daily basis to ensure they have both AFO categories for the study. Conventional Ankle Foot Orthoses have been more commonly used in past decades. AFOs within the conventional category generally include designs that will not return stored energy in late stance. These designs may vary in material construction and componentry. For instance, mechanical joints can be incorporated but do not have to be for inclusion in this group. AFOs in this category may be thermoplastic materials or thermoset laminate. The devices may be off-the-shelf or custom molded to the patient.

    Also known as: Conventional AFO, Traditional AFO

06

What researchers measure

Primary outcomes

  1. Timed Up & Go

    The Timed Up\& Go (TUG) assesses mobility. In this test, subjects are timed while they rise from a chair, walk 3m, turn around, return to the chair and sit down again. Subjects are usually permitted to use a walking aid, but not to use physical assistance.

    Time frame: After 3-week accommodation period with device A and after 3-week accommodation period with device B.

  2. Two-minute Walk Test

    The Two-minute Walk Test (2MWT) assesses walking ability. Subjects will be asked to walk the greatest distance they can in 2 minutes while walking a 15.2m 'out and back' course until asked to stop. The distance walked will be recorded as will the post-test rate of perceived exertion (6-20 Borg RPE scale).

    Time frame: After 3-week accommodation period with device A and after 3-week accommodation period with device B.

  3. Four-Square-Step-Test

    The Four-Square-Step-Test is a balance and agility test where the patient changes direction quickly while maintaining balance. A 1-inch-high obstacle in the shape of a Maltese cross is placed on the floor. The patient is instructed to begin in the back, left quadrant then to move 1) forward, 2) sideways right, 3) backward, then 4) sideways left, then to move in the reverse direction back to the original square. They move as fast as possible through their movement progression while always keeping one foot on the floor.

    Time frame: After 3-week accommodation period with device A and after 3-week accommodation period with device B.

  4. Activities-Specific Balance Confidence Scale

    The Activities-Specific Balance Confidence Scale (ABC Scale) is a 16-item self-report tool that measures an individual's confidence in performing daily activities without losing balance or feeling unsteady. Participants rate their confidence for each activity on a 0% to 100% scale where 0% indicates no confidence and 100% indicates complete confidence.

    Time frame: After 3-week accommodation period with device A and after 3-week accommodation period with device B.

  5. Patient-Reported Outcomes Measurement Information System (PROMIS)

    The Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference (PROMIS-PI) is a standardized, self-reported tool designed to assess the extent to which pain disrupts a person's daily activities and quality of life. The PROMIS-PI evaluates the impact of pain on social, physical, emotional and cognitive functioning. Responses are rated on a 5-point scale from "never" to "very much" regarding how pain interfered with activities in the past week.

    Time frame: After 3-week accommodation period with device A and after 3-week accommodation period with device B. Monthly for 12 months after accommodation period with device B.

  6. Orthotics and Prosthetics Users' Survey (OPUS)

    The OPUS is a self-report questionnaire consisting of five modules. The following four modules related to the lower extremity will be used: 1) Lower Extremity Functional Status Measure, 2) Health Related Quality of Life Index, 3) Satisfaction with Devices and 4) Satisfaction with Services. The first two modules are based on a five-point Likert scale and nominal Yes/No scale while the latter two use a four-point Likert scale. Higher scores indicate better outcomes.

    Time frame: After 3-week accommodation period with device A and after 3-week accommodation period with device B. Monthly for 12 months after accommodation period with device B.

Secondary outcomes

  1. Preference

    Interviews with participants will be used to identify overall preference and device preference for different activities. Interviews will also ask about the specific needs, preferences, challenges, and limitations of using each device.

    Time frame: Before and after each accommodation and training period. At 12 month follow-up.

  2. Activity monitoring

    The activity monitors will measure active and sedentary periods of behavior. Specific variables estimated will include - time spent sitting, standing, stepping, time spent in sedentary, light and moderate-to-vigorous intensity activity, time spent in prolonged sitting bouts (e.g., sitting bouts \> 30 min, \> 60 min etc.), time spent in bouts of moderate-to-vigorous intensity (e.g., \> 10 minute bouts, i.e., activity bouts known to improve health), number of steps per day and number of sit-to-stand transitions per sedentary time.

    Time frame: Monthly for 12 months after initial two accommodation and training periods

07

Study locations

3 of 3 sites recruiting
  • University of South Florida, Rehabilitation Robotics & Prosthetics Testbed (RRT)
    Tampa, Florida 33620, United States
    Recruiting
    • Stephanie L Carey, PhD · Contactscarey3@usf.edu · 813-974-5765
    • Stephanie L Carey, PhD · Principal investigator
  • James A. Haley VA Center of Innovation of Disability & Rehab Research
    Tampa, Florida 33637, United States
    Recruiting
  • VA New York Harbor Healthcare System
    New York, New York 10010, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07721792
Collaborators
Tampa VA Healthcare System, VA New York Harbor Healthcare System
Responsible party
Sponsor
First posted
Jul 23, 2026
Start date
Jul 31, 2026 (estimated)
Primary completion
Jan 10, 2029 (estimated)
Completion
Jan 31, 2029 (estimated)
Last update
Jul 23, 2026

Study contacts

Stephanie L Carey, PhD
Contact
scarey3@usf.edu
813-974-5765

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion